AU2018284131B2 - Synthesis of substantially diastereomerically pure phosphate protides - Google Patents

Synthesis of substantially diastereomerically pure phosphate protides Download PDF

Info

Publication number
AU2018284131B2
AU2018284131B2 AU2018284131A AU2018284131A AU2018284131B2 AU 2018284131 B2 AU2018284131 B2 AU 2018284131B2 AU 2018284131 A AU2018284131 A AU 2018284131A AU 2018284131 A AU2018284131 A AU 2018284131A AU 2018284131 B2 AU2018284131 B2 AU 2018284131B2
Authority
AU
Australia
Prior art keywords
compound
diastereoisomer
formula
mixture
formula ila
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018284131A
Other languages
English (en)
Other versions
AU2018284131A1 (en
Inventor
Venkata Lakshmi Narasimha Rao Dammalapati
Hugh GRIFFITH
Gordon KENNOVIN
Mani Bushan KOTALA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nucana PLC
Original Assignee
Nucana PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nucana PLC filed Critical Nucana PLC
Publication of AU2018284131A1 publication Critical patent/AU2018284131A1/en
Application granted granted Critical
Publication of AU2018284131B2 publication Critical patent/AU2018284131B2/en
Priority to AU2022204691A priority Critical patent/AU2022204691B2/en
Priority to AU2024200428A priority patent/AU2024200428B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/02—Phosphorylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2018284131A 2017-06-14 2018-06-14 Synthesis of substantially diastereomerically pure phosphate protides Active AU2018284131B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2022204691A AU2022204691B2 (en) 2017-06-14 2022-06-30 Synthesis of substantially diastereomerically pure phosphate protides
AU2024200428A AU2024200428B2 (en) 2017-06-14 2024-01-24 Synthesis of substantially diastereomerically pure phosphate protides

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1709471.5A GB201709471D0 (en) 2017-06-14 2017-06-14 Diastereoselective synthesis of hosphate derivatives
GB1709471.5 2017-06-14
PCT/GB2018/051638 WO2018229493A2 (en) 2017-06-14 2018-06-14 Synthesis of phosphate derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2022204691A Division AU2022204691B2 (en) 2017-06-14 2022-06-30 Synthesis of substantially diastereomerically pure phosphate protides

Publications (2)

Publication Number Publication Date
AU2018284131A1 AU2018284131A1 (en) 2020-01-16
AU2018284131B2 true AU2018284131B2 (en) 2022-04-07

Family

ID=59358400

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2018284131A Active AU2018284131B2 (en) 2017-06-14 2018-06-14 Synthesis of substantially diastereomerically pure phosphate protides
AU2022204691A Active AU2022204691B2 (en) 2017-06-14 2022-06-30 Synthesis of substantially diastereomerically pure phosphate protides
AU2024200428A Active AU2024200428B2 (en) 2017-06-14 2024-01-24 Synthesis of substantially diastereomerically pure phosphate protides

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2022204691A Active AU2022204691B2 (en) 2017-06-14 2022-06-30 Synthesis of substantially diastereomerically pure phosphate protides
AU2024200428A Active AU2024200428B2 (en) 2017-06-14 2024-01-24 Synthesis of substantially diastereomerically pure phosphate protides

Country Status (18)

Country Link
US (4) US11414452B2 (OSRAM)
EP (2) EP3638684A2 (OSRAM)
JP (4) JP7248209B2 (OSRAM)
KR (2) KR102695300B1 (OSRAM)
CN (3) CN110753697B (OSRAM)
AU (3) AU2018284131B2 (OSRAM)
BR (1) BR112019026747A2 (OSRAM)
CA (2) CA3065682A1 (OSRAM)
CL (1) CL2019003632A1 (OSRAM)
EA (1) EA201992873A1 (OSRAM)
GB (1) GB201709471D0 (OSRAM)
IL (3) IL312228B2 (OSRAM)
MA (1) MA49379A (OSRAM)
MX (3) MX391332B (OSRAM)
PH (1) PH12019502825A1 (OSRAM)
SA (1) SA519410795B1 (OSRAM)
SG (1) SG11201911543UA (OSRAM)
WO (2) WO2018229493A2 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20160346T1 (hr) 2011-03-01 2016-05-06 Nucana Biomed Limited Fosforoamidatni derivati 5-fluoro-2'-deoksiuridina za upotrebu u tretmanu raka
DK3119794T3 (en) 2014-06-25 2018-01-22 NuCana plc FORMULA CONTAINING A GEMCITABIN PRODRUG
KR102548806B1 (ko) 2014-11-28 2023-06-27 뉴카나 피엘씨 항암제로서 새로운 2' 및/또는 5' 아미노산 에스테르 포스포르아미데이트 3'-디옥시아데노신 유도체
WO2017098252A1 (en) 2015-12-11 2017-06-15 Nucana Biomed Limited Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug nuc-1031
GB201522764D0 (en) 2015-12-23 2016-02-03 Nucana Biomed Ltd Formulations of phosphate derivatives
GB201609600D0 (en) 2016-06-01 2016-07-13 Nucuna Biomed Ltd Cancer treatments
GB201709471D0 (en) 2017-06-14 2017-07-26 Nucana Biomed Ltd Diastereoselective synthesis of hosphate derivatives
GB201715011D0 (en) 2017-09-18 2017-11-01 Nucana Biomed Ltd Floxuridine synthesis
CN112409421A (zh) * 2020-12-01 2021-02-26 上海兆维科技发展有限公司 一种3’-磷酸酯核苷的制备方法
CN119546313A (zh) 2022-05-12 2025-02-28 努卡那有限公司 使用nuc-7738的癌症治疗
EP4630433A1 (en) 2022-12-07 2025-10-15 NuCana plc Synthesis of nucleoside derivative nuc-3373

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016030335A1 (en) * 2014-08-25 2016-03-03 Medivir Ab Dioxolane analogues of uridine for the treatment of cancer
WO2016083830A1 (en) * 2014-11-28 2016-06-02 Nucana Biomed Limited New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds
WO2016098123A2 (en) * 2014-12-16 2016-06-23 Laurus Labs Private Ltd A recycling process for preparing (s)-2-[(substituted-phenoxy)-phenoxy- phosphorylamino] propionic acid isopropyl ester diastereomers
WO2017207989A1 (en) * 2016-06-01 2017-12-07 Nucana Biomed Limited Adenosine derivatives for use in the treatment of cancer

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE279248C (OSRAM)
US3792039A (en) 1971-12-27 1974-02-12 Miles Lab Poly 2'-fluoro-2'-deoxyuridylic acid
US4500707A (en) * 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4357324A (en) 1981-02-24 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
US4668777A (en) * 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
ES2172303T3 (es) 1998-01-23 2002-09-16 Newbiotics Inc Agentes terapeuticos obtenidos por catalisis enzimatica.
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
GB0317009D0 (en) 2003-07-21 2003-08-27 Univ Cardiff Chemical compounds
CA2589935A1 (en) 2004-12-09 2006-06-15 Regents Of The University Of Minnesota Nucleosides with antiviral and anticancer activity
GB0505781D0 (en) 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
CN101287472B (zh) 2005-08-15 2011-10-12 弗·哈夫曼-拉罗切有限公司 抗病毒的4'-取代前核苷酸的氨基磷酸酯类化合物
GB0623493D0 (en) 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
US20080261913A1 (en) * 2006-12-28 2008-10-23 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of liver disorders
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US20090206007A1 (en) 2008-02-20 2009-08-20 Air Products And Chemicals, Inc. Process and apparatus for upgrading coal using supercritical water
CA2749394A1 (en) 2009-01-09 2010-07-15 University College Of Cardiff Consultants Limited Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
EP2623104A1 (en) 2009-03-20 2013-08-07 Alios Biopharma, Inc. Substituted nucleoside and nucleotide analogs
TWI598358B (zh) 2009-05-20 2017-09-11 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
WO2011123668A2 (en) 2010-03-31 2011-10-06 Pharmasset, Inc. Stereoselective synthesis of phosphorus containing actives
JP5872539B2 (ja) 2010-03-31 2016-03-01 ギリアド ファーマセット エルエルシー プリンヌクレオシドホスホルアミダート
EP2805960A1 (en) 2010-07-19 2014-11-26 Gilead Sciences, Inc. Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
US20120070411A1 (en) 2010-09-22 2012-03-22 Alios Biopharma, Inc. Substituted nucleotide analogs
US8871737B2 (en) 2010-09-22 2014-10-28 Alios Biopharma, Inc. Substituted nucleotide analogs
EP2646453A1 (en) 2010-11-30 2013-10-09 Gilead Pharmasset LLC Compounds
EP2655392B1 (en) 2010-12-22 2018-04-18 Alios Biopharma, Inc. Cyclic nucleotide analogs
HRP20160346T1 (hr) * 2011-03-01 2016-05-06 Nucana Biomed Limited Fosforoamidatni derivati 5-fluoro-2'-deoksiuridina za upotrebu u tretmanu raka
US9556216B2 (en) 2012-08-31 2017-01-31 Novartis Ag 2′-Ethynyl nucleoside derivatives for treatment of viral infections
ES2627195T3 (es) 2012-11-16 2017-07-27 University College Cardiff Consultants Limited Mezcla de RP/SP gemcitabina-[fenil-(bencloxi-l-alaninil)]-fosfato
CA2913206C (en) 2013-06-26 2022-08-02 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
ES2927955T3 (es) 2013-09-11 2022-11-14 Univ Emory Composiciones de nucleótidos y nucleósidos y sus usos
WO2015054465A1 (en) 2013-10-11 2015-04-16 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
KR20160099090A (ko) 2013-11-27 2016-08-19 아이데닉스 파마슈티칼스 엘엘씨 간암의 치료를 위한 뉴클레오티드
CZ307789B6 (cs) * 2014-04-15 2019-05-09 Zentiva, K.S. Způsob výroby biologicky účinných fosforamidátových léčiv
WO2015161137A1 (en) 2014-04-16 2015-10-22 Idenix Pharmaceuticals, Inc. 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
DK3119794T3 (en) 2014-06-25 2018-01-22 NuCana plc FORMULA CONTAINING A GEMCITABIN PRODRUG
WO2015198058A1 (en) 2014-06-25 2015-12-30 Nucana Biomed Limited Gemcitabine prodrugs
CN106795198B (zh) 2014-07-22 2019-09-06 努卡那公共有限公司 用于制备吉西他滨-[苯基(苄氧基-l-丙氨酸基)]磷酸酯的方法
GB201417644D0 (en) 2014-10-06 2014-11-19 Nucana Biomed Ltd Method of separating phosphate diastereoisomers
CN105646629A (zh) 2014-11-25 2016-06-08 广州市恒诺康医药科技有限公司 L-核苷类化合物及其应用
WO2016145142A1 (en) 2015-03-10 2016-09-15 Emory University Nucleotide and nucleoside therapeutics compositions and uses related thereto
MX390506B (es) 2015-05-14 2025-03-20 NuCana plc Nuc-1031 (gemcitabina-[fenil-benzoxi-l-alaninil])-fosfato) para usarse en el tratamiento neoadyuvante y adyuvante en pacientes con cáncer.
CN106543252A (zh) 2015-09-16 2017-03-29 博瑞生物医药（苏州）股份有限公司 核苷氨基磷酸酯类前药的制备方法及其中间体
CN106543220A (zh) 2015-09-16 2017-03-29 博瑞生物医药（苏州）股份有限公司 氨基磷酸酯化合物及其制备方法和晶体
CN106478753A (zh) 2015-09-16 2017-03-08 博瑞生物医药（苏州）股份有限公司 一种nuc‑1031单一异构体的制备方法和用途
EA037248B1 (ru) 2015-10-05 2021-02-26 НУКАНА ПиЭлСи Применение гемцитабин[фенил-бензокси-l-аланинил]фосфата в комбинации с карбоплатином
CN108431016A (zh) 2015-11-16 2018-08-21 艾可瑞恩治疗公司 核酸前体药物
WO2017098252A1 (en) 2015-12-11 2017-06-15 Nucana Biomed Limited Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug nuc-1031
ES2778933T3 (es) 2015-12-23 2020-08-12 NuCana plc Terapia de combinación
GB201522764D0 (en) 2015-12-23 2016-02-03 Nucana Biomed Ltd Formulations of phosphate derivatives
GB201609601D0 (en) 2016-06-01 2016-07-13 Nucana Biomed Ltd Phosphoramidate compounds
GB201609600D0 (en) 2016-06-01 2016-07-13 Nucuna Biomed Ltd Cancer treatments
GB201709471D0 (en) 2017-06-14 2017-07-26 Nucana Biomed Ltd Diastereoselective synthesis of hosphate derivatives
GB201713916D0 (en) 2017-08-30 2017-10-11 Nucana Biomed Ltd Treatment regimens

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016030335A1 (en) * 2014-08-25 2016-03-03 Medivir Ab Dioxolane analogues of uridine for the treatment of cancer
WO2016083830A1 (en) * 2014-11-28 2016-06-02 Nucana Biomed Limited New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds
WO2016098123A2 (en) * 2014-12-16 2016-06-23 Laurus Labs Private Ltd A recycling process for preparing (s)-2-[(substituted-phenoxy)-phenoxy- phosphorylamino] propionic acid isopropyl ester diastereomers
WO2017207989A1 (en) * 2016-06-01 2017-12-07 Nucana Biomed Limited Adenosine derivatives for use in the treatment of cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
McGuigan, C. et al.; J. Med. Chem., 54, 7247-7258 (2011). DOI: 10.1021/jm200815w. *
Ross, B. S. et al.; J. Org. Chem., 76, 8311-8319 (2011). DOI:10.1021/jo201492m. *
Serpi, M. et al.; ChemistryOpen, 6, 424-436 (2017). DOI: 10.1002/open.201700019. *
Simmons, B. et al.; Org. Lett., 19, 2218-2221 (2017). DOI: 10.1021/acs.orglett.7b00469. *

Also Published As

Publication number Publication date
KR102695300B1 (ko) 2024-08-16
US20220402962A1 (en) 2022-12-22
JP2024138523A (ja) 2024-10-08
CN110785425B (zh) 2023-11-21
CN110785425A (zh) 2020-02-11
IL302559B2 (en) 2024-09-01
WO2018229493A2 (en) 2018-12-20
MX390901B (es) 2025-03-21
IL312228B2 (en) 2025-06-01
IL271159B2 (en) 2023-10-01
US11414452B2 (en) 2022-08-16
KR20200016864A (ko) 2020-02-17
JP7248209B2 (ja) 2023-03-29
US20200181186A1 (en) 2020-06-11
US11897913B2 (en) 2024-02-13
KR20240127483A (ko) 2024-08-22
WO2018229495A1 (en) 2018-12-20
IL271159A (en) 2020-01-30
IL312228B1 (en) 2025-02-01
US12054511B2 (en) 2024-08-06
US20250171487A1 (en) 2025-05-29
MX2022003822A (es) 2022-05-25
EA201992873A1 (ru) 2020-05-19
BR112019026747A2 (pt) 2020-06-30
SG11201911543UA (en) 2020-01-30
JP2023095954A (ja) 2023-07-06
CL2019003632A1 (es) 2020-08-14
AU2024200428A1 (en) 2024-02-08
AU2018284131A1 (en) 2020-01-16
MX391332B (es) 2025-03-21
GB201709471D0 (en) 2017-07-26
IL302559B1 (en) 2024-05-01
WO2018229493A3 (en) 2019-02-07
EP3638684A2 (en) 2020-04-22
CN110753697A (zh) 2020-02-04
CN117486959A (zh) 2024-02-02
JP7279991B2 (ja) 2023-05-23
CA3064177A1 (en) 2018-12-20
EP3638685A1 (en) 2020-04-22
JP7525687B2 (ja) 2024-07-30
AU2022204691A1 (en) 2022-08-04
US20200181190A1 (en) 2020-06-11
MA49379A (fr) 2020-04-22
IL271159B1 (en) 2023-06-01
IL312228A (en) 2024-06-01
MX2019014907A (es) 2020-02-13
MX2019014914A (es) 2020-02-13
JP2020523378A (ja) 2020-08-06
AU2024200428B2 (en) 2025-10-16
CN110753697B (zh) 2023-10-13
IL302559A (en) 2023-07-01
CA3065682A1 (en) 2018-12-20
SA519410795B1 (ar) 2023-11-19
AU2022204691B2 (en) 2023-11-23
JP2020523381A (ja) 2020-08-06
PH12019502825A1 (en) 2020-10-26

Similar Documents

Publication Publication Date Title
AU2022204691B2 (en) Synthesis of substantially diastereomerically pure phosphate protides
AU2016367237B2 (en) Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug NUC-1031
EP3172218B1 (en) Process for the preparation of gemcitabine-[phenyl(benzoxy-l-alaninyl)] phosphate
EP3684780B1 (en) Floxuridine synthesis
EA043691B1 (ru) Получение фосфатных производных
EA047265B1 (ru) Получение фосфатных производных
HK1232546B (en) Process for the preparation of gemcitabine-[phenyl(benzoxy-l-alaninyl)] phosphate
HK1232546A1 (en) Process for the preparation of gemcitabine-[phenyl(benzoxy-l-alaninyl)] phosphate

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)